LYCOS RETRIEVER 
Epilepsy
built 221 days ago
Epilepsy is a term used for recurring seizure disorder, a condition that is characterized by the tendency for an individual to have repeated nervous seizures (interruption of normal brain activity). In 2004, the prevalence of epilepsy was estimated to be approximately six million people across the seven major pharmaceutical markets (France, Germany, Italy, Spain, UK, USA and Japan). By 2015, it is predicted that 6.4 million people will be living with epilepsy. Epilepsy is currently treated with older traditional anti-epileptic drugs (AEDs) and second-generation AEDs, with the former marketed before 1980, and the latter class marketed in the early 1990s. Today's AEDs are only effective in treating disease symptoms. Currently, between 70% and 80% of patients are successfully treated with one of the more than 20 anti-epileptic drugs now available.
Source:
Epilepsy is a physical condition that starts in the brain (a neurological condition). It is a sign that the way a person’s brain works is sometimes disrupted. When this happens, a person may suddenly have a seizure. Many people will have a single seizure at some time in their lives, but this does not mean that they have epilepsy. If a person has epilepsy it means they have had more than one seizure beginning in the brain.
Source:
Epilepsy and the medications to treat it can have many effects on the mother, the pregnancy, and the fetus and newborn. Fortunately, most women are able to have a healthy pregnancy and baby. However, epilepsy does increase the risks for certain complications of pregnancy. These include the following:
Source:
The International Organizing Committee and the Scientific Advisory Committee of the 7th Asian & Oceanian Epilepsy Congress are honoured to have the support of the Ministry of Health P.R. China for this regional congress in Xiamen.
Source:
Medtronic, Inc. announced the start of the U.S. pivotal clinical trial for the Intercept™ Epilepsy Control System, the company’s brain stimulation therapy that may reduce seizure rates in patients with epilepsy. Epilepsy is a condition that affects 2.3 million Americans, and about one-third of these patients continue to experience seizures despite a wide range of treatment options. The therapy is designed to disrupt the circuits suspected of influencing epileptic seizures. The system provides bilateral brain stimulation using three implantable components: a neurostimulator (implanted in the chest), extensions (two small, insulated wires that are threaded from the neurostimulator to the head) and leads (electrodes that are implanted in the thalamus). The neurostimulator generates electrical pulses that are delivered directly to the brain by the extensions and leads. These pulses can be non-invasively adjusted by a clinician from a physician programmer and transmitted via telemetry to the implanted device. (Medtronic 4/13/04)
Source:
The Epilepsy Center of NW Ohio is a non profit organization offering services and information about epilepsy to any one who is affected by epilepsy in the 13 counties in Northwest Ohio. These counties include: Eric, Sandusky, Ottawa, Wood, Lucas, Henry, Fulton, Williams, Defiance, and Paulding.
Source:
MORE ABOUT
Epilepsy